close
Breaking news

A new line of argument has already come to dominate the public sphere: it’...read more The government has gone one step further to detect community spread of the coro...read more The government has issued an order to abolish the six allowances, including the...read more Aarogya Setu application launched by NIC is aimed to track COVID-19 affected pe...read more SEOUL| South Korea’s unemployment rate was unchanged in April as the coronavi...read more Amid the outbreak of Corona pandemic in the country, Indian government has been...read more Prime Minister Narendra Modi in his address to the nation on Tuesday indicated ...read more Corona infection in the country is taking a macabre form. So far, more than 74 ...read more Congress General Secretary Priyanka Gandhi Vadra has written a letter to UP Chi...read more On Tuesday, Prime Minister Narendra Modi announced a package of Rs 20 lakh cror...read more

Patanjali Corona Medicine Stuck in Controversies

Patanjali Corona Medicine

The coronil and inhaled medicine launched by Patanjali as a corona drug has been mired in controversies. After stopping the publicity of the medicine by the Union Ministry and calling upon the Uttarakhand Government to respond in this regard, the State Government has cornered itself on this issue. The state’s AYUSH department says that Patanjali was given a license to become an immunity booster. Find out how the Corona drug was made and why the drug kit was advertised. A notice will be issued to Patanjali on behalf of Ayush Drugs License Authority.

Dr. YS Rawat, in charge of Ayurveda Drugs License Authority, says that Patanjali was given a license to make immunity boosters and fever, cough medicine. No license to manufacture corona medicine is given. A notice will be issued to Patanjali on this.

The Union Ministry of AYUSH has sought an answer from Patanjali Ayurved. In a statement issued to the ministry on Tuesday, it has been said that the ministry has no information about Patanjali’s claims. The ministry has come to know through the news. The ministry has therefore ordered an immediate ban on the promotion of drug claims.

According to the ministry, Patanjali Ayurved Limited has been asked to provide complete information about the ingredients involved in the medicine, research, protocol, identification of patients (on which the study took place), CTRI registration, study results, etc. at the earliest. Uttarakhand State Licensing Authority has been asked to approve the license and the documents related to the drug. Also, until the scrutiny of the documents is completed, the promotion of the drug is immediately banned.

Story Page

Download Our Mobile App